Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130) on September 21, 2023. The Pharmaceutical business generated annual sales of KRW 313.9 billion in 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48,700 KRW | -0.10% |
|
-4.88% | -27.64% |
28/05 | SK Chemicals Introduces Sustainable Packaging Solutions | MT |
21/05 | SK Chemicals Implements Safety Evaluation System at Ulsan Plant | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.64% | 639M | |
-3.43% | 37.41B | |
-31.06% | 19.19B | |
-28.03% | 11.17B | |
-20.30% | 8.99B | |
+27.74% | 8.77B | |
-13.36% | 5.54B | |
-43.42% | 4.45B | |
-26.89% | 3.56B | |
+12.88% | 2.76B |
- Stock Market
- Equities
- A285130 Stock
- News SK Chemicals Co.,Ltd
- Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd.